Press Releases May 14, 2026 04:15 PM

United Community Banks, Inc. Announces Quarterly Cash Dividend on Common Stock

United Community Banks declares $0.25 quarterly cash dividend, reflecting strong financial health and commitment to shareholders

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
UCB

United Community Banks, Inc. announced a quarterly cash dividend of $0.25 per share, payable on July 3, 2026, to shareholders of record as of June 15, 2026. The company's robust financial position is highlighted by $28.2 billion in assets and a widespread regional presence with 200 offices. Renowned for customer satisfaction and multiple industry awards, United Community Banks continues its commitment to shareholder returns and strong community banking services.

United Community Banks, Inc. Announces Quarterly Cash Dividend on Common Stock
UCB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Board approved a $0.25 per share quarterly cash dividend payable July 3, 2026.
  • Company holds $28.2 billion in assets with 200 regional offices across Southeastern states.
  • United Community Banks is highly recognized for customer satisfaction and has received multiple industry awards including J.D. Power and Forbes distinctions.

GREENVILLE, S.C., May 14, 2026 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (the “Company”), reported that its Board of Directors approved a quarterly cash dividend of $0.25 per share on the Company’s common stock. The dividend is payable on July 3, 2026 to shareholders of record as of June 15, 2026.

About United Community

United Community Banks, Inc. (NYSE: UCB) is the financial holding company for United Community, a top-100 U.S. financial institution committed to building stronger communities and improving the financial health and well-being of its customers. United Community offers a full range of banking, mortgage and wealth management services. As of March 31, 2026, United Community Banks, Inc. had $28.2 billion in assets and operated 200 offices across Alabama, Florida, Georgia, North Carolina, South Carolina and Tennessee. The Company also manages a nationally recognized SBA lending franchise and an equipment finance subsidiary, extending its reach to businesses across the country. United Community is the most awarded bank in the Southeast for Retail Banking Customer Satisfaction by J.D. Power, earning more awards than any other bank in the region, including recognition in 12 of the last 17 years. The Company has also been named one of the “Best Banks to Work For” by American Banker for nine consecutive years. In commercial banking, United Community earned multiple 2026 Greenwich Best Bank awards for Small Business Banking. Forbes has consistently named United Community among the World’s Best and America’s Best Banks. Learn more at ucbi.com.

For more information:
Jefferson Harralson
Chief Financial Officer
(864) 240-6208
Jefferson_Harralson@ucbi.com


Risks

  • Dividend payments depend on future earnings and cash flow; economic downturns could impact ability to maintain payouts.
  • Regional economic shifts in the Southeastern U.S. could affect bank performance and asset quality.
  • Competition in retail and commercial banking sectors may impact market share and profitability.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026